Pretreatment of Acute Coronary Syndrome With Dual Antiplatelet Agents
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJordan Collaborating Cardiology Group
About this trial
This is a chart review of data on use of antiplatelet (AP) medications for acute coronary syndrome in the ER. Guidelines recommend giving aspirin in the ER and a second AP agent in the cath lab. What is the outcome when the 2 agents are given n the ER?
Eligibility criteria
Qualifiers
Adult patients
Presenting with acute coronary syndrome (ST segment elevation myocardial infarction, non ST segment elevation myocardial infarction, and unstable angina).
Antiplatelet medication (s) prescribed during index admission to hospital.
Willingness of the patient to be called for follow up up to 1 year after index hospitalization.
Disqualifiers
Non cardiac chest pain.
No administration of antiplatelet agents during hospitalization.
Refusal of contact for follow up.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
200 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov